مقایسه ی اثر دو داروی پرومتازین و افدرین بر ثبات علایم حیاتی بیماران تحت عمل آرتروپلاستی (تعویض مفصل) با بی‌حسی نخاعی به همراه مصرف سیمان

نویسندگان

1 رزیدنت بیهوشی و مراقبت های ویژه، دانشگاه علوم پزشکی جهرم،جهرم،ایران

2 دانشیاردانشگاه علوم پزشکی جهرم،بخش بیهوشی و مراقبت های ویژه، دانشگاه علوم پزشکی جهرم،جهرم،ایران

3 دانشیاردانشگاه علوم پزشکی جهرم،بخش بیهوشی و مراقبت های ویژه،دانشگاه علوم پزشکی جهرم،جهرم،ایران

4 مربی، گروه بیهوشی، دانشگاه علوم پزشکی جهرم،جهرم،ایران

چکیده

مقدمه: درعمل های جراحی تعویض مفصل به علت مصرف سیمان، به دلایل متعدد بی‌حسی نخاعی بر بیهوشی عمومی ترجیح داده می‌شود. اثرات جانبی سیمان بر سیستم قلب و عروق بیماران می‌تواند فاجعه‌بار باشد، یافتن روش های درمانی مناسب به منظور کاهش عوارض سیمان ضروری است.
 روش کار: در این کارآزمایی بالینی 90 نفر از بیماران کاندیدای عمل  تعویض مفصل به سه گروه سی نفره تقسیم شدند. گروه اول 25میلی‌گرم پرومتازین وریدی، گروه دوم 10 میلی‌گرم افدرین وریدی و گروه کنترل معادل حجم دو گروه موردمطالعه‚ آب مقطر وریدی 10 دقیقه قبل از تزریق سیمان دریافت کردند.علائم حیاتی بیماران بدو ورود به اتاق عمل، بعد از بی‌حسی نخاعی، بلافاصله قبل از تزریق دارو، بعد از تزریق، پنج دقیقه و ده دقیقه بعد از تزریق سیمان ثبت شد. تحلیل داده ها به روش آمار توصیفی و استنباطی انجام شد.
یافته ها: بین گروه‌های پرومتازین، افدرین و کنترل از نظر فشارخون سیستول در زمان‌های بعد از تزریق دارو،  پنج و ده دقیقه بعد از سیمان و فشارخون دیاستول نیز در ده دقیقه بعد از سیمان تفاوت آماری معناداری مشاهده شد (0.05>p ). همچنین بین گروه‌های مورد مطالعه از لحاظ ضربان قلب در پنج دقیقه بعد از سیمان تفاوت معنادار بود (0.041=p )، اما از نظر اکسیژن خون شریانی تفاوت معنادار نبود (0.09=p ).
نتیجه‌گیری: براساس نتایج پژوهش درهنگام عمل جراحی تعویض مفصل به همراه تزریق سیمان، استفاده از افدرین و پرومتازین می‌تواند بر ثبات علائم حیاتی بیماران مؤثر بوده و به پایداری فشارخون سیستول (افدرین) و فشارخون دیاستول و ضربان قلب (پرومتازین) کمک کند تا عوارض این دسته عمل های جراحی به حداقل برسد.

کلیدواژه‌ها

عنوان مقاله [English]

Comparison of the effect of promethazine and ephedrine on the stability of vital signs in patients undergoing arthroplasty (joint replacement) with spinal anesthesia with cement

نویسندگان [English]

  • Azin Hamidi 1
  • Mohammad Radmehr 2
  • Reza Sahraei 3
  • navid kalani 4
  • Mohammad Sadegh Sanie Jahromi 3

1 Resident anesthesia and intensive care, Jahrom University of Medical Sciences, Jahrom, Iran

2 Associate Professor of Anesthesiology, Anesthesiology, Critical care and pain management research center, Jahrom University of Medical Sciences, Jahrom, Iran

3 Associate Professor of Anesthesiology, Anesthesiology, Critical care and pain management research center, Jahrom University of Medical Sciences, Jahrom, Iran

4 Tutor, Anesthesiology, Anesthesiology, Critical care and pain management research center, Jahrom University of Medical Sciences, Jahrom, Iran

چکیده [English]

Introduction: In arthroplasty, spinal anesthesia was preferred to general anesthesia for a variety of reasons due to the
use of cement. The side effects of cement on the cardiovascular system of patients, which can be catastrophic, it's necessary to find appropriate treatment methods to reduce side effects of cement.
Materials and Methods: In this clinical trial, 90 patients were arthroplasty candidates divided into three groups. The first group 25 mg intravenous promethazine, the second 10 mg intravenous ephedrine and the control group the equivalent volume of distilled intravenous water 10 minutes before cement injection received. Hemodynamic symptoms of patients entering the operating room, after spinal, immediately before injection. The drug was recorded after injection, five and ten minutes after cement injection. Data analysis by descriptive and inferential levels.
Results: Promethazine and ephedrine and control groups in systolic blood pressure at the time after drug injection and five and ten minutes after cement and diastolic blood pressure at 10 minutes after cement were significant(p<0.05). There was a significant difference between the study groups in heart rate at five minutes after cementing (p=0.041) but no significant difference in terms of O2 SAT at time of arrival (p=0.09).
Conclusion: According to the results of the study, in patients with arthroplasty by injection of cement due to hemodynamic changes, the use of ephedrine and promethazine can affect the hemodynamic stability of patients and help stabilize systolic blood pressure (ephedrine) and diastolic blood pressure and heart rate (promethazine) to minimize the complications of these surgeries.

کلیدواژه‌ها [English]

  • Arthroplasty
  • Cement
  • Ephedrine
  • Promethazine
1-Minns Lowe CJ, Barker KL, Dewey M, Sackley CM. Effectiveness of physiotherapy exercise after knee arthroplastyfor osteoarthritis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2007; 335: 812. 2. Browne C, Copp S, Reden L, Pulido P, Colwell C, Jr. Bupivacaine bolus injection versus placebo for pain management following total knee arthroplasty. J Arthroplasty 2004; 19(3): 377-80. 3-Arden N, Blanco F, Cooper C, Guermazi A, Hayashi D, Hunter D, Javaid MK, Rannou F, Roemer FW, Reginster JY (2015). Atlas of Osteoarthritis. Springer. p. 21. ISBN 4-Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ (July 2015). "Osteoarthritis". Lancet. 386 (9991): 376–87. doi:10.1016/S0140-6736(14)60802-3. PMID 25748615. 5-National Institute of Arthritis and Musculoskeletal and Skin Diseases. April 2015. Archived from the original on 18 May 2015. Retrieved 13 May 2015. 6-Sinusas K (January 2012). "Osteoarthritis: diagnosis and treatment". American Family Physician. 85 (1): 49–56. PMID 22230308. 7-Brandt KD, Dieppe P, Radin E (January 2009). "Etiopathogenesis of osteoarthritis". The Medical Clinics of North America. 93 (1): 1–24, xv. doi:10.1016/j.mcna.2008.08.009. PMID 19059018 8- Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B, Herrero-Beaumont G, Kirschner S, Leeb BF, Lohmander LS, Mazières B, Pavelka K, Punzi L, So AK, Tuncer T, Watt I, Bijlsma JW (March 2010). "EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis". Annals of the Rheumatic Diseases. 69 (3): 483–9. doi:10.1136/ard.2009.113100. PMID 19762361 9- McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, Hawker GA, Henrotin Y, Hunter DJ, Kawaguchi H, Kwoh K, Lohmander S, Rannou F, Roos EM, Underwood M (March 2014). "OARSI guidelines for the non-surgical management of knee osteoarthritis". Osteoarthritis and Cartilage. 22 (3): 363–88. doi:10.1016/j.joca.2014.01.003. PMID 24462672. 10-Di Puccio F, Mattei L (January 2015). "Biotribology of artificial hip joints". World Journal of Orthopedics. 6 (1): 77–94. doi:10.5312/wjo.v6.i1.77. PMC 4303792. PMID 25621213 11- Santaguida PL, Hawker GA, Hudak PL, Glazier R, Mahomed NN, Kreder HJ, Coyte PC, Wright JG (December 2008). "Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review". Canadian Journal of Surgery. Journal Canadien De Chirurgie. 51 (6): 428–36. PMC 2592576. PMID 19057730. 12- Carr AJ, Robertsson O, Graves S, Price AJ, Arden NK, Judge A, Beard DJ (April 2012). "Knee replacement". Lancet. 379 (9823): 1331–40. doi:10.1016/S0140-6736(11)60752-6. PMID 22398175 13. Busch CA, Shore BJ, Bhandari R, Ganapathy S, MacDonald SJ, Bourne RB, et al. Efficacy of periarticular multimodal drug injection in total knee arthroplasty. A randomized trial. J Bone Joint Surg Am 2006; 88(5): 959-63. 14. Rasmussen S, Kramhoft MU, Sperling KP, Pedersen JH. Increased flexion and reduced hospital stay with continuous intraarticular morphine and ropivacaine after primary total knee replacement: open intervention study of efficacy and safety in 154 patients. Acta Orthop Scand 2004; 75(5): 606-9. 15. Chen J, Rizzo JA, Parasuraman S, Gunnarsson C. Racial disparities in receiving total hip/knee replacement surgery: The effect of hospital admission sources. Journal of Health Carefor the Poor and Underserved. 2013; 24(1): 135-51. 16-. Bruyere O, Ethgen O, Neuprez A, Zegels B, Gillet P, Huskin JP, et al. Health-related quality of life after total knee or hip replacement for osteoarthritis: A 7-year prospective study.Archives of Orthopaedic and Trauma Surgery. 2012; 132(11): 1583-7. 17-Guyton JL. Arthroplasty of knee. In: Canale ST, ed.Campbell’s Operative Orthopaedics. 11thed. Philadelphia: Mosby; 2008. p 241-311. 18- Biau D, Mullins MM, Judet T, Piriou P. Is anyone too old for a total knee replacement? Clin Orthop Relat Res. 2006;448:180-4. 19-Fcarcsi G,FRCA E. Bone cement and the implication for anaesthesia.Continuing education in anaesthesia critical care and pain.2012;p 213-216. 20-. Andersen HL, Gyrn J, Moller L, Christensen B, Zaric D. Continuous saphenous nerve block as supplement to single-dose local infiltration analgesia for postoperative pain management after total knee arthroplasty. Regional Anesthesia and Pain Medicine. 2013; 38(2): 106-11. 21-Miller R.D. Miller’s Anesthesia, 7th edition. 2010; Epidural and spinal anesthesia. 22- Borzouei B, and Mousavi Bahar S.H, Results of Percutaneous Nephrolithotomy under Spinal Anesthesia. International Journal of Medical and Biological Sciences. 2012; 7:465-8 23- Miller RD, Lee A. Miller`s Anesthesia. 6th. New York: Churchil Leving Stone. 2005; p: 1621 24-Katzung BG. Basic and clinical pharmacology, 3rd ed, USA, Appletone & Lange Co. 2008: 268. 25-Simons FE. Anaphylaxis: evidence-based long-term risk reduction in the community. Immunol Allergy Clin North Am 2007; 27:231. 26-"Ephedrine". The American Society of Health-System Pharmacists. Archived from the original on 2017-09-08. Retrieved Jan 2016. Check date values in: |accessdate= (help) 27- Briggs, Gerald G.; Freeman, Roger K.; Yaffe, Sumner J. (2011). Drugs in pregnancy and lactation : a reference guide to fetal and neonatal risk (9th ed.). Philadelphia: Lippincott Williams & Wilkins. p. 495. ISBN 9781608317080. Archived from the original on 2017-09-08. 28-"Ephedrine Pregnancy and Breastfeeding Warnings". Archived from the original on 8 September 2017. Retrieved 27 January 2016. 29-GOODMAN & GILMAN'S THE PHARMACOLOGICAL BASIS OF THERAPEUTICS - 11th Ed. (۲۰۰۶) 30-Lieberman M, Marks A, Peet A (2013). Marks' Basic Medical Biochemistry: A Clinical Approach (4th ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 175. ISBN 9781608315727. 31-Bell DR (2009). Medical physiology : principles for clinical medicine (3rd ed.). Philadelphia: Lippincott Williams & Wilkins. p. 312. ISBN 9780781768528. 32-Khurana (2008). Essentials of Medical Physiology. Elsevier India. p. 460. ISBN 9788131215661. 33- Shen, Howard (2008). Illustrated Pharmacology Memory Cards: PharMnemonics. Minireview. p. 4. ISBN 1-59541-101-1. 34-Sabyasachi Sircar (2007). Medical Physiology. Thieme Publishing Group. p. 536. ISBN 3-13-144061-9. 35-Guideline 11.5: Medications in Adult Cardiac Arrest" (PDF). Australian Resuscitation Council. December 2010. Retrieved 7 March 201 36-"Promethazine Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 24 October 2018. 37- British national formulary : BNF 74 (74 ed.). British Medical Association. 2017. p. 276. ISBN 978-0857112989. 38-Malamed, Stanley F. (2009). Sedation: A Guide to Patient Management. Elsevier Health Sciences. p. 113. ISBN 0323075967. 39-Starke P, Weaver J, Chowdhury B (2005). "Boxed warning added to promethazine labeling for pediatric use". N. Engl. J. Med. 352 (5): 2653. doi:10.1056/nejm200506233522522. 40- Miller RD,Anestheia 6th ED, new york churchill livingstone 2010:30 – 39 41.Renter?a-Zamarr?n D, Cortés-Hern?ndez DA, Bretado-Arag?n L, et al. Mechanical properties and apatite-forming ability of PMMA bone cements. Materials & Design 2009;30(8):3318-24. 42.Van Gool AV. Preformed polymethylmethacrylate cranioplasties: Report of 45 cases. J of Maxillofacial Surg 1985;13(1):2-8. 43.Kim SB, Kim YJ, Yoon TL, et al. The characteristics of a hydroxyapatite chitosan PMMA bone cement. Biomaterials 2004;25(26):5715-23. 44.Pascual B, Gurruchaga M, Ginebra MP, et al. Modified acrylic bone cement with high amounts of ethoxytriethyleneglycol methacrylate. J Biomaterials 1999;20(6):453-63. 45.Pharmacology uptodate, promethazine, Pharmacokinetics and pharmacodynamics, 2021. 46.Ephedrin.The american society of health system pharmacists.archieved from the original on 2017-9-9 retrieved 8 september 2017. 47-Race A, Miller MA, Mann KA. A modified PMMA cement (Sub-cement) for accelerated fatigue testing of cemented implant constructs using cadaveric bone. J Biomech 2008;41(14):3017-23. 48-Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR. Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA. 2012; 308(12):1227-36. 49-Maheshwari AV, Argawal M, Naziri Q, Pivec R, Mont MA, Rasquinha VJ. Can cementing technique reduce the cost of a primary total knee arthroplasty? J Knee Surg. 2015; 28(3):183-90. 50-Silverman EJ, Landy DC, Massel DH, Kaimrajh DN, Latta LL, Robinson RP. The effect of viscosity on cement penetration in total knee arthroplasty, an application of the squeeze film effect. J Arthroplasty. 2014; 29(10):2039-42. 51-Byrick RJ, Forbes D, Waddell JP. A monitored cardiovascular collapse during cemented total knee replacement. Anesthesiology. 1986;65: 213‐215. 52- Olsen F, Kotyra M, Houltz E, Ricksten S-E. Bone cement implantation syndrome in cemented hemiarthroplasty for femoral neck fracture: incidence, risk factors, and effect on outcome. Br J of Anaesthesia. 2014;113:800‐806. 53- Donaldson A, Thomson H, Harper N, Kenny N. Bone cement implantation syndrome. Br J Anaesthesia. 2009;102:12‐22. 54- Modig J, Malmberg P. Pulmonary and circulatory reactions during total hip replacement surgery. Acta Anaesthesiol Scand 1975;19:219–237. [PubMed: 241194] 55- Lopez-Duran L, Garcia-Lopez A, Duran L, Hurtado J, Ruiz C, Rodrigo JL. Cardiopulmonary and haemodynamic changes during total hip arthroplasty. Int Orthop 1997;21:253–258. [PubMed:9349963] 56-Mansouri M,Bahador A.The effect of zolpidem and promethazine premedication on agitation,sedation and cognitive disorders before and after coronary artery bypass graft surgery.isfahan medical university1394;495. 57-Zand F.Preventive effect of ephedrin to counteract hemodynamic changes following induction of anesthesia with propofol and remifentanil.IRCT 2012; 58-Farzi F,Mirmansouri A,Jalali M,Mohtasham a Z.Effect of IV and intramuscular Ephedrin and IV Atropin to prevent decrease blood pressure in c/s patients.journal of advances in medical and biomedical research1381cited 2021;10(40):1-8. 59-Alijanpour E,Rabiei M,Akbari A.Hemodynamic change in patients with prophylactic ephedrin before spinal anesthesia.JBUMS2000,2(4):7-11. 60-Segerstad M,Olsen F,Patel A,Houltz E,Bengt N,Ricksten S.Pulmunary haemodynamics and right ventricular function in cemented vs uncemented total hip arthroplasty a randomized trial.Acta anaesthesiologica scandinavica 2018;63(3).DOI:10.1111/aas.13262. 61-M H Ereth,JG Weber,M D abel,R L Lennon,D G Lewallen,D M IIstrup,K Rehder.Cemented versus noncemented total hip arthroplasty embolism hemodynamic and intrapulmunary shunting.Mayo clinic proc.1992nov;67(11):1066-74.doi:10.1016/s0025-6196(12)61121-25. 62-Helgason B,Stirnimann P,Widmer R,Boger A,Ferguson S.J.Influence of cement stiffness and bone morphology on the compressive properties of bone cement composites in simulated vertebroplasty.journal of biomedical materials research2012;101B:364-374.DOI.org/10.1002/jbm.b.32847. 63-Dahl O E,Garvik L J,Lyberg T.Toxic effects of methylmethacrylate monomer on leukocytes and endothelial cells in vitro.Acta orthopaedica scandinavica1994;65(2),147-153. 64-Meng Guo,Bao Guo,Zhong G,Dian Y.Effect of cement implantation and pressor agents in hip replacement on blood pressure.Journal of peking university.2013oct;45(5):693-7. 65-Tryba M,Linde I,Voshage G,Zenz M..Histamine release and cardiovascular reactions to implantation of bone cement during total hip replacement.1991 jan;40(1):25-32. 66-Hagen A,Doldersum P,Raaij TV.Anaphylactic shock during cement implantation of a total hip arthroplasty in a patient with underlying mastocytosis case report of a rare intraoperative complication.Patient safety in surgery2016nov;25.